CHD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.276600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.594800E-01
Normal-vs-Stage2
4.418800E-01
Normal-vs-Stage3
2.709600E-01
Normal-vs-Stage4
3.352600E-01
Stage1-vs-Stage2
9.195400E-01
Stage1-vs-Stage3
4.743600E-02
Stage1-vs-Stage4
9.515800E-01
Stage2-vs-Stage3
1.232350E-01
Stage2-vs-Stage4
9.722600E-01
Stage3-vs-Stage4
9.506000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.274800E-01
Normal-vs-AfricanAmerican
4.775200E-01
Normal-vs-Asian
1.114390E-01
Caucasian-vs-AfricanAmerican
5.999800E-01
Caucasian-vs-Asian
3.173400E-01
AfricanAmerican-vs-Asian
3.486000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.281600E-01
Normal-vs-Female
4.299800E-01
Male-vs-Female
9.670400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.631800E-01
Normal-vs-Age(41-60Yrs)
5.571000E-01
Normal-vs-Age(61-80Yrs)
3.827800E-01
Normal-vs-Age(81-100Yrs)
3.526200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.318400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.960000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.794600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.404700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.466200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.750800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.270100E-02
Normal-vs-Daily Drinker
3.838800E-01
Normal-vs-Weekly Drinker
3.283200E-01
Normal-vs-Occasional Drinker
4.546200E-01
Normal-vs-Social Drinker
4.294000E-01
Non Drinker-vs-Daily Drinker
7.350800E-01
Non Drinker-vs-Weekly Drinker
3.288200E-01
Non Drinker-vs-Occasional Drinker
5.828400E-01
Non Drinker-vs-Social Drinker
8.429600E-01
Daily Drinker-vs-Weekly Drinker
4.078400E-01
Daily Drinker-vs-Occasional Drinker
3.260400E-01
Daily Drinker-vs-Social Drinker
5.404000E-01
Weekly Drinker-vs-Occasional Drinker
8.090400E-02
Weekly Drinker-vs-Social Drinker
1.661170E-01
Occasional Drinker-vs-Social Drinker
7.319200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.787600E-02
Normal-vs-Grade 2
3.635200E-03
Normal-vs-Grade 3
3.343300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.415400E-01
Grade 1-vs-Grade 3
6.904800E-01
Grade 1-vs-Grade 4
5.787600E-02
Grade 2-vs-Grade 3
7.224600E-01
Grade 2-vs-Grade 4
3.635200E-03
Grade 3-vs-Grade 4
3.343300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.811200E-01
Normal-vs-NonDiabetic
4.142000E-01
Diabetic-vs-NonDiabetic
4.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.234000E-01
Normal-vs-NoPancreatitis
4.044600E-01
Pancreatitis-vs-NoPancreatitis
8.660400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.904800E-01
Normal-vs-N1
4.483200E-01
N0-vs-N1
2.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.905200E-01
Normal-vs-TP53-NonMutant
4.612400E-01
TP53-Mutant-vs-TP53-NonMutant
6.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
